Amrutajan Health Care Gears Up for Q3 Reveal on 3rd February; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Amrutajan Health Care’s Q3 results FY26 are scheduled to be announced on 3rd February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Amrutajan Health Care Q3 Results 2026 Preview

• Amrutajan Health Care’s revenue is expected to be in the range of ₹122.75 crore, a 11.68% YoY increase. 
• Profit After Tax, or PAT, is projected to rise by 63.16% YoY. 
• Net profit is ₹19.25 crore, up 63.16% YoY 
• EBITDA to rise 81.48%

Amrutajan Health Care Share Performance 

• Over the past six months, Amrutajan Health Care’s share price has fallen by 14.81% to ₹573.35.
• Moreover, over the past year, the stock has decreased by 13.53%.
• Despite this weak short-term performance, Amrutajan Health Care’s stock has delivered a financially sound 11.36% return over the past 5 years.
• As of 3rd February 2026, the stock traded at ₹575.45 per share.

Key Factors to Watch for Amrutajan Health Care Q3 Results FY26 

• Revenue Growth: How much sales have grown — especially in pain relief, women’s hygiene, and rehydration segments — compared to last year.
  
• Profitability & Margins: EBITDA and net profit margins to see cost control and operational efficiency in the quarter.
  
• Seasonality & Demand Trends: Q3 is typically a strong season for products like balms and rehydration solutions — watch if demand remains robust.
  
• Product Mix & New Launches: Impact of new products or expansion into adjacent categories (like Comfy, Electro+) on overall growth.
  
• Cash Flow / Balance Sheet Strength: Debt levels, cash generation, and receivables management (e.g., debtor turnover) for financial health signposts. 

Final Thoughts

Amrutajan Health Care will announce its Q3 FY26 results on 2nd February 2026. Analysts expect 11.68% YoY revenue growth, a 63.16% rise in PAT, and a 81.48% rise in EBITDA. Amrutanjan Health Care focuses on consumer healthcare products, including pain relief balms, women’s hygiene products, and rehydration solutions, with an emphasis on brand strength, seasonal demand, and margin improvement.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here